跳至主要内容
临床试验/NCT01172600
NCT01172600已完成不适用

Effect of Nitrous Oxide in Treating Neuropathic Pain: A Pilot Study in Chronic Low Back Pain Patients

The Cleveland Clinic2 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
78
试验地点
2
主要终点
Change in VAS Pain Score From Baseline to Before 3rd Block

研究概览

简要总结

Epidural injection will be completed under fluoroscopy and all patients will receive 1-4 mg of Midazolam for relaxation before procedure and, if needed, 50-100 mcg of Fentanyl intravenous (IV). Radiopaque contrast (Omnipaque 300), for confirming the epidural position of the needle, steroids and local anesthetic agents will be used according to the physician performing the block and will not be controlled by the study. Patients will be randomly assigned to receive either inhaled Entonox along with the interventional block they are scheduled for or oxygen. They will be blinded about the treatment they are receiving. Those randomized to Entonox will inhale the gas through a mouthpiece throughout the procedure and also continue to receive it for a total of 4 hours in the recovery. Those randomized to the oxygen group will receive oxygen through a similar mouthpiece for the entire duration of the procedure and recovery for 4 hours. Following completion of procedure the patient will be transferred to recovery and monitored for 3-5 hours then discharged home with instructions. Possible side effects will be monitored and recorded, pain score of patient will be recorded before discharge. All the patients will receive standard instructions regarding physical back exercises. This will be repeated for every procedure up to maximum of three blocks.

The patients will be followed during each block and over a period of 1, 3, 6 and 12 months and on each follow-up visit will complete computerized set of questionnaires as they did before the procedure. The patients charts will be then reviewed for one year after the initial procedure to determine if further epidural steroid injections or surgery for the presenting problem were required. It is anticipated that the appropriate number of patients will be enrolled within six months of study initiation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 80 years old at time of the first procedure
  • Male or female
  • History of chronic low back pain for longer than 6 months due to radiculopathy, symptomatic spinal canal stenosis, disc prolapse, postlaminectomy syndrome
  • magnetic resonance imaging or electromyographic evidence of nerve root damage
  • Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) score of >12
  • No or minimal evidence of facet joint pathology

排除标准

  • Known contraindications for epidural injection
  • Patients with ongoing workers' compensation claims
  • unstable or heavy opioid use (400 mg of morphine equivalents daily),
  • psychiatric disorders
  • medical illness, including conditions that could interfere with the interpretation of the outcome assessments
  • pregnant or lactating women
  • Current or recent drug abuse (within past 6 months).
  • Patient refuses regional analgesia.
  • Alcohol or drug abuse

结局指标

主要结局

Change in VAS Pain Score From Baseline to Before 3rd Block

时间窗: At baseline (before 1st block) and before the 3rd block, typically at 2 months from baseline

10-cm-long Visual Analog Scale (VAS) pain score, ranges from 0 (no pain) to 10 (worst pain imaginable). It was measured before 1st 2nd and 3rd block and at 3 month follow-up. The primary outcome was the change in VAS pain score from baseline (before 1st block) to before the 3rd block

Change in VAS Pain Score From Baseline to Before 2nd Block

时间窗: At baseline (before 1st block) and before the 2nd block, typically at 1 month from baseline

10-cm-long Visual Analog Scale (VAS) pain score, ranges from 0 (no pain) to 10 (worst pain imaginable). It was measured before 1st 2nd and 3rd block and at 3 month follow-up. The primary outcome was the change in VAS pain score from baseline (before 1st block) to before the 2nd block.

Change in VAS Pain Score From Baseline to 3 Month Follow-up

时间窗: At baseline (before 1st block) and 3 months follow-up after last block (maximum of 3 blocks with a typical 1 month interval between blocks)

10-cm-long Visual Analog Scale (VAS) pain score, ranges from 0 (no pain) to 10 (worst pain imaginable). It was measured before 1st 2nd and 3rd block and at 3 month follow-up. The primary outcome was the change in VAS pain score from baseline (before 1st block) to the 3 month follow-up.

次要结局

  • Change in Oswestry Score (% of Disability) From Baseline to 3rd Block(At baseline (before 1st block) and before the 3rd block, typically at 2 months from baseline)
  • Usage of Opioids(2nd block, typically at 1 month from baseline)
  • Change in Oswestry Score (% of Disability) From Baseline to 3 Months Follow-up(At baseline (before 1st block) and 3 months follow-up after last block (maximum of 3 blocks with a typical 1 month interval between blocks))
  • Change in Oswestry Score (% of Disability) From Baseline to 2nd Block(At baseline (before 1st block) and before the 2nd block, typically at 1 month from baseline)
  • Usage of Opioid(3 months follow-up after last block (maximum of 3 blocks with a typical 1 month interval between blocks))
  • Biomarkers(3 months follow-up after last block (maximum of 3 blocks with a typical 1 month interval between blocks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alparslan Turan

Alparslan Turan, M.D.

The Cleveland Clinic

研究点 (2)

Loading locations...

相似试验

Effect of Nitrous Oxide in Treating Neuropathic... | 临床试验